期刊： THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022; 15 ()
Introduction: Few data have been published on the ethnic sensitivity of effectiveness, pharmacokinetics (PK), and pharmacodynamics (PD) of avatrombopa......
期刊： THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022; 15 ()
Non-variceal upper gastrointestinal bleeding (NVUGIB) is a common type of upper gastrointestinal emergency with high risk of life-threatening conditio......
期刊： THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022; 15 ()
Introduction: Linaclotide, a guanylate cyclase C agonist that improves the symptoms of irritable bowel syndrome with predominant constipation (IBS-C),......
期刊： THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022; 15 ()
Background: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccine is thought to be the most effective preventive method of controll......
期刊： THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022; 15 ()
Background: The quality of randomized crossover studies on digestive diseases is unclear. We aimed to review crossover trials in digestive disease jou......
期刊： THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022; 15 ()
Background: Liver cirrhosis is a major global health burden worldwide due to its high risk of morbidity and mortality. Role of terlipressin for the ma......
期刊： THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022; 15 ()
Background: Behcet's disease (BD) is a relapsing systemic immune disorder, and intestinal BD is a significant cause of mortality in patients with BD. ......
期刊： THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022; 15 ()
Background: As a novel drug, vonoprazan (VPZ) has been developed as a new strategy against Helicobacter pylori (H. pylori) infections. However, whethe......
期刊： THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022; 15 ()
Background: The past decade has witnessed a dramatic increase in the number of patients with inflammatory bowel disease (IBD) in China. The nationwide......
期刊： THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022; 15 ()
Background: Raltitrexed plus S-1 (RS) and regorafenib both showed considerable efficacy for metastatic colorectal cancer (mCRC) patients. This study a......
期刊： THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022; 15 ()
Gastroesophageal reflux disease (GERD) is a common disease with increasing prevalence worldwide. However, the diagnosis of GERD is challenging because......
期刊： THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022; 15 ()
Background: The Coronavirus Disease 2019 (COVID-19) pandemic poses a massive crisis to global public health. Gastrointestinal (GI) symptoms are increa......
期刊： THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022; 15 ()
Intestinal strictures remain one of the most intractable and common complications of Crohn's disease (CD). Approximately 70% of CD patients will devel......
期刊： THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022; 15 ()
Acid suppression is the primary therapy for erosive esophagitis (EE). Although proton pump inhibitors (PPIs) are considered as the first-line medicati......
期刊： THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022; 15 ()
Background: Oral microbiota reported to be associated with pancreatic diseases, including pancreatic cancer. However, the association of oral microbio......
